Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer: Results From the PROSINT Phase 2 Randomized Clinical Trial.

导出 LinkOut

翻译打印收藏纠错

作者： Carlo,Greco ^[1] ; Oriol,Pares ^[1] ; Nuno,Pimentel ^[1] ; Vasco,Louro ^[1] ; Inês,Santiago ^[1] ; Sandra,Vieira ^[1] ; Joep,Stroom ^[1] ; Dalila,Mateus ^[1] ; Ana,Soares ^[1] ; João,Marques ^[1] ; Elda,Freitas ^[1] ; Graça,Coelho ^[1] ; Manuela,Seixas ^[1] ; Antonio,Lopez-Beltran ^[1] ; Zvi,Fuks ^[1]

作者单位： The Champalimaud Centre for the Unknown, Lisbon, Portugal. ^[1] Memorial Sloan Kettering Cancer Center, New York, New York. ^[2]

主题词人类(Humans);男(雄)性(Male);肿瘤复发, 局部(Neoplasm Recurrence, Local);前列腺特异抗原(Prostate-Specific Antigen);前列腺切除术(Prostatectomy);前列腺肿瘤(Prostatic Neoplasms);生活质量(Quality of Life);放射外科手术(Radiosurgery);治疗结果(Treatment Outcome)

DOI 10.1001/jamaoncol.2021.0039

PMID 33704378

发布时间 2022-05-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAMA oncology

2021年7卷5期

700-708页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer: Results From the PROSINT Phase 2 Randomized Clinical Trial.

JAMA oncology

相似文献

JAMA oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer: Results From the PROSINT Phase 2 Randomized Clinical Trial.

JAMA oncology

相似文献

JAMA oncology

相关期刊

检索历史清除